![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Abdel-Aleem H, EL-Nushar I, Abdel-Aleem A. Management of severe postpartum hemorrhage with misoprostol. International Journal of Gynaecology and Obstetrics 2001; 72: 75
- Combs C A, Murphy E L, Laros R K, Jr. Factors associated with hemorrhage in caesarean deliveries. Obstetrics and Gynecology 1991; 77: 77–82
- El-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 1997; 104: 336–339
- Evron S, Ariely S, Agasi M, Eger G, Bukovsky I, Caspi E, et al. Severe peripheral arteriospasm following oxytocin administration. American Journal of Obstetrics and Gynecology 1986; 155: 657–658
- Gary C F, Whitridge W J. Williams Obstetrics. 22nd ed. McGraw-Hill, New York 2005
- Gerstenfeld T S, Wing D A. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. American Journal of Obstetrics and Gynecology 2001; 185: 878
- Gulmezoglu A M, Villar J, Nigoc N T, Piaggio C, Adetoro L, et al. WHO multicenter randomized trial of misoprostol in the management of the third stage of labor. Lancet 2001; 358: 689–695
- Hoj L, Cardoso P, Nielsen B B, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health center in Guinea-Bissau: randomized double blind clinical trial. British Medical Journal 2005; 331: 723
- Klassen G A, Rubin J W, McGregor M. The effect of synthetic oxytocin on impaired atrioventricular conduction. American Journal of Cardiology 1963; 12: 523–526
- Lam H, Tung O S, Lee P C. A pilot randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstetricia et Gynecologica Scandinavica 2004; 83: 647–650
- Lapaire O, Schneider M C, Stotz M, Surbek D V, Holzgreve W, Hoesli I M, et al. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery. International Journal of Gynaecology and Obstetrics 2006; 95: 2–7
- Prendiville W, Elbourne D. Care during the third stage of labour. Effective care in pregnancy and childbirth, I Chalmers, M Enkin, M JNC Kerise. Oxford University Press, Oxford 1989; 1145–1169
- Ramsey P S, Ramin K D. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstetrics and Gynecology 1999; 93: 157–158
- Robinson M, Newman N, Greevy C, Katz J, Harrison D C. Congenital aortic stenosis in pregnancy – ventricular fibrillation induced by oxytocin. Journal of the American Medical Association 1967; 5: 108–111
- Senior J, Marshall K, Sangha R, Clayton J K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. British Journal of Pharmacology 1993; 108: 501–506
- Svanström M C, Biber B, Hanes M, Johansson G, Näslund U, Bålfors E M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. British Journal of Anaesthesia 2008; 100: 683–689
- Thomas J S, Koh S H, Cooper G M. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. British Journal of Anaesthesia 2007; 98: 116–119
- Tang O S, Schweer H, Seyberth H W, Lee S W, Ho P C. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 2002; 17: 332–336
- Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at caesarean section. International Journal of Gynaecology and Obstetrics 2006; 92: 106–110
- WHO. Postpartum care of the mother and the newborn: a practical guide. Safe motherhood unit. World Health Organization, Geneva 1998